A thorough and independent review has been conducted on these vaccines. In 2023 the TGA has decided that the following vaccines meet the high safety, efficacy and quality standards required for use in Australia. This is in addition to the vaccines approved in 2022 and 2021.
For a list of COVID-19 vaccines provisionally approved in 2023, 2022 and 2021 see COVID-19 vaccine: Provisional registrations.
Related links
Product types
Topics
Latest articles
-
GMP Annex 6 and Annex 15 concept papers - Open for public consultation
News articlesInformation on the recently announced concept papers proposing to update the Good Manufacturing Practice (GMP) guide for Annex 6 and Annex 15. -
Update to listed medicine ingredients in March 2026
Regulatory decision noticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2026, which commenced on 1 March 2026. -
New resources on market actions and minor PRAC updates
News articlesWe have published a new FAQ and Guidance page on the use of legislative powers related to recalls and other market actions.